IXHL
Price
$0.43
Change
-$0.03 (-6.52%)
Updated
Oct 1, 04:59 PM (EDT)
Capitalization
40.49M
NBIX
Price
$137.05
Change
-$3.33 (-2.37%)
Updated
Oct 1, 04:59 PM (EDT)
Capitalization
13.59B
33 days until earnings call
Interact to see
Advertisement

IXHL vs NBIX

Header iconIXHL vs NBIX Comparison
Open Charts IXHL vs NBIXBanner chart's image
Incannex Healthcare
Price$0.43
Change-$0.03 (-6.52%)
Volume$143.94K
Capitalization40.49M
Neurocrine Biosciences
Price$137.05
Change-$3.33 (-2.37%)
Volume$28.59K
Capitalization13.59B
IXHL vs NBIX Comparison Chart in %
Loading...
IXHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IXHL vs. NBIX commentary
Oct 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IXHL is a Buy and NBIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 02, 2025
Stock price -- (IXHL: $0.46 vs. NBIX: $140.38)
Brand notoriety: IXHL and NBIX are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: IXHL: 43% vs. NBIX: 129%
Market capitalization -- IXHL: $40.49M vs. NBIX: $13.59B
IXHL [@Pharmaceuticals: Generic] is valued at $40.49M. NBIX’s [@Pharmaceuticals: Generic] market capitalization is $13.59B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $65.13B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IXHL’s FA Score shows that 0 FA rating(s) are green whileNBIX’s FA Score has 1 green FA rating(s).

  • IXHL’s FA Score: 0 green, 5 red.
  • NBIX’s FA Score: 1 green, 4 red.
According to our system of comparison, NBIX is a better buy in the long-term than IXHL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IXHL’s TA Score shows that 1 TA indicator(s) are bullish while NBIX’s TA Score has 3 bullish TA indicator(s).

  • IXHL’s TA Score: 1 bullish, 7 bearish.
  • NBIX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, NBIX is a better buy in the short-term than IXHL.

Price Growth

IXHL (@Pharmaceuticals: Generic) experienced а -30.88% price change this week, while NBIX (@Pharmaceuticals: Generic) price change was -4.11% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.59%. For the same industry, the average monthly price growth was +38.73%, and the average quarterly price growth was +90.63%.

Reported Earning Dates

NBIX is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.59% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NBIX($13.6B) has a higher market cap than IXHL($40.5M). NBIX YTD gains are higher at: 2.842 vs. IXHL (-78.099). NBIX has higher annual earnings (EBITDA): 557M vs. IXHL (-21.34M). NBIX has more cash in the bank: 976M vs. IXHL (6.71M). IXHL has less debt than NBIX: IXHL (1.69M) vs NBIX (439M). NBIX has higher revenues than IXHL: NBIX (2.51B) vs IXHL (98K).
IXHLNBIXIXHL / NBIX
Capitalization40.5M13.6B0%
EBITDA-21.34M557M-4%
Gain YTD-78.0992.842-2,748%
P/E RatioN/A40.53-
Revenue98K2.51B0%
Total Cash6.71M976M1%
Total Debt1.69M439M0%
FUNDAMENTALS RATINGS
NBIX: Fundamental Ratings
NBIX
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
72
SMR RATING
1..100
58
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
26
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IXHLNBIX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
56%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
58%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 9 days ago
79%
Bullish Trend 14 days ago
72%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 17 days ago
58%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
IXHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
WSML30.250.08
+0.28%
iShares MSCI World Small-Cap ETF
HYBB47.31-0.04
-0.08%
iShares BB Rated Corporate Bond ETF
DBC22.53-0.09
-0.40%
Invesco DB Commodity Tracking
YXI9.60-0.06
-0.57%
ProShares Short FTSE China 50
LABD40.44-1.04
-2.51%
Direxion Daily S&P Biotech Bear 3X ETF

IXHL and

Correlation & Price change

A.I.dvisor tells us that IXHL and INM have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IXHL and INM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IXHL
1D Price
Change %
IXHL100%
-10.54%
INM - IXHL
24%
Poorly correlated
-3.52%
ESPR - IXHL
23%
Poorly correlated
+0.38%
NBIX - IXHL
22%
Poorly correlated
+0.08%
HROW - IXHL
22%
Poorly correlated
-0.45%
YCBD - IXHL
20%
Poorly correlated
-12.32%
More